Abstract
Skeletal muscle is a highly heterogeneous tissue that plays a crucial role in mammalian metabolism and motion maintenance. Myogenesis is a complex biological process that includes embryonic and postnatal development, which is regulated by specific signaling pathways and transcription factors. Various non-coding RNAs (ncRNAs) account for the majority of total RNA in cells and have an important regulatory role in myogenesis. In this review, we introduced the research progress in miRNAs, circRNAs, and lncRNAs related to embryonic and postnatal muscle development. We mainly focused on ncRNAs that regulate myoblast proliferation, differentiation, and postnatal muscle development through multiple mechanisms. Finally, challenges and future perspectives related to the identification and verification of functional ncRNAs are discussed. The identification and elucidation of ncRNAs related to myogenesis will enrich the myogenic regulatory network, and the effective application of ncRNAs will enhance the function of skeletal muscle.
Introduction
Skeletal muscle is a highly heterogeneous tissue that contains myofibers, the basement membrane, muscle satellite cells, immunocytes, and nerves, and plays a crucial role in locomotion, metabolism, and homeostasis. In mice and humans, this tissue represents ~30–40% of the total body mass (Zierath and Hawley, 2004). The molecular regulation of the skeletal muscle during embryonic and postnatal development is complex. Many aspects of adult myogenesis resemble embryonic morphogenetic episodes (Bentzinger et al., 2012). In vertebrate embryos, the skeletal muscles of the trunk and limbs are derived from the paraxial mesoderm and first form a certain number of somites (Bentzinger et al., 2012). Somites undergo morphogenetic changes and differentiate into sclerotome and dermomyotome, and muscle progenitor cells (MPCs) delaminate from the surrounding of the dermomyotome under the regulation of the Shh, Notch, and Wnt signaling pathways (Grefte et al., 2007). At this stage Myf5 and Mrf4, independently of Pax3/7, regulate the entry of MPCs into the myogenic program. MPCs express Pax3 and Pax7 genes, and migrate to the limbs and trunk (Buckingham and Relaix, 2007). However, some MPCs give rise to a subpopulation of postnatal muscle stem cells called satellite cells (SCs) (Gros et al., 2005). Both MPCs and SCs can give rise to myoblasts to complete myogenesis. The committed myoblast undergo proliferation, exit the cell cycle, express myogenic regulatory factors (MRFs), undergo morphological changes, fusing to form multinucleated myotubes. Finally, these myotubes are further fused into mature myofibers (Tajbakhsh, 2009) (Figure 1). Six1/4 and Pax3/7 are master regulators of MPCs but not SCs during early lineage specification, whereas Myf5 and MyoD commit MPCs and SCs to the myogenic program. MPCs and SCs expression of the terminal differentiation genes are performed by both myogenin (MyoG) and MyHC (Bentzinger et al., 2012). Skeletal muscle is composed of multinucleated contractile myofibers. Studies have shown that committed myoblasts align and fuse to generate small multinucleated myofibers during primary myogenesis in the embryo [from embryonic day 11 (E11)-E14.5]; during secondary myogenesis (from E14.5-to birth), the formation of myofibers containing hundreds of myonuclei are regulated via numerous signaling pathways and transcription factors (Sambasivan and Tajbakhsh, 2007).
Figure 1

Coding genes and ncRNAs regulate the process of embyronic and postnatal myogenesis. Coding genes are represented in red squares, ncRNAs are represented in blue squares.
SCs reside between the sarcolemma and basal lamina of myofibers (Mauro, 1961). SCs can serve as a pathway for skeletal muscle fiber growth after birth by activating myogenesis, repairing muscle fiber damage, or prolonging muscle fiber growth (Grounds and Yablonka-Reuveni, 1993). Under normal conditions, SCs express Pax7 and remain in a state of mitotic quiescence (Cheung and Rando, 2013). When muscles are stimulated or injured, SCs are immediately activated, proliferated, and differentiated like myoblasts. Finally, these cells fuse with the original myofibers or fuse with each other into myotubes and connect to the tail of old myofibers to form new myofibers (Zammit et al., 2006). This process is called postnatal muscle development (Relaix and Zammit, 2012). The SC population is a heterogeneous mixture of stem cells and committed progenitors (Le Grand and Rudnicki, 2007), and proliferates and divides into two daughter cells in an “asymmetric” pattern after activation (Kuang et al., 2007). Using chromosome orientation-fluorescence in situ hybridization in transgenic Tg:Pax7-nGFP mice, Rocheteau et al. (2012) demonstrated that all chromatids segregate asymmetrically in SCs. Cho and Doles used single cell RNA sequencing (scRNA-seq) to study the transcriptional diversity of freshly isolated skeletal muscle SCs and found the extensive transcriptional heterogeneity between individual SCs (Cho and Doles, 2017). Single-cell mass spectrometry revealed the heterogeneity of skeletal muscle SC in the activation of myogenesis in vitro and in vivo (Porpiglia et al., 2017).
Both embryonic myogenesis and postnatal skeletal muscle development is a highly regulated process; each step of the process is regulated by specific signaling pathways and transcription factors such as Sonic hedgehog (Shh), Notch, Wnt, and bone morphogenetic protein 4 (BMP4) (Jin et al., 2016), especially MRFs and post-transcriptional regulation by ncRNAs (Pauli et al., 2011; Zammit, 2017). The Encyclopedia of DNA Elements (Consortium) project showed that 80% of the eukaryotic genome is transcribed (Consortium, 2012), but <2% of total genomic sequences are transcribed into mature protein-coding RNAs, and the vast majority of transcripts are ncRNAs (Cheng et al., 2005). Various ncRNAs account for the majority of total RNA in cells. ncRNAs include tRNA, rRNA, eRNA, mitochondrial ncRNAs, micro (mi) RNAs, long non-coding (lnc) RNAs, circular (circ) RNAs, and PIWI-interacting RNAs (pi) RNAs (de Gonzalo-Calvo and Thum, 2018). Furthermore, ncRNAs are involved in diverse biological processes, and an increasing number of studies have shown that ncRNA-mediated epigenetic regulation plays an important role in myogenesis. In this review, we mainly focused on the importance of miRNAs, circRNAs, and lncRNAs in embryonic myogenesis and postnatal skeletal muscle development, and discussed their regulation of muscle disease. Finally, challenges and future perspectives in the identification of novel muscle-related ncRNAs were discussed.
miRNAs and Myogenesis
miRNA and Embryonic Myogenesis
miRNAs are a class of small RNAs that are 20–24 nucleotides in length, and regulate the expression of target messenger RNAs (mRNAs) through base-pairing with the 3′ untranslated regions (3′UTRs) (Bartel, 2009). This interaction leads to inhibition of translation, mRNA cleavage, and transcript degradation (Bethune et al., 2012). This mechanism reportedly guides a diverse set of RNA-induced silencing complexes (RISC) to target mRNAs (Schraivogel and Meister, 2014). The biogenesis of most miRNAs depends on specific RNA processing enzymes, including Drosha and its essential cofactor DGCR8, Dicer (Bushati and Cohen, 2007). Dicer activity is essential for normal muscle development during embryogenesis, and Dicer muscle-specific mutants reduced muscle miRNAs and led to a decrease in myofiber development by reducing muscle mass and perinatal lethality in mice (O'Rourke et al., 2007). The role of miRNAs during embryogenesis was explored in zebrafish. Giraldez and colleagues generated maternal-zygotic Dicer (MZdicer) mutants that disrupted the Dicer ribonuclease III and double-stranded RNA-binding domains. MZdicer mutants displayed abnormal morphogenesis during gastrulation, somitogenesis, and heart development. Mutant embryos failed to process precursor miRNAs into mature miRNAs, but injecting preprocessed miRNAs restored gene silencing, indicating that miRNAs are essential for early embryogenesis (Giraldez et al., 2005). A growing number of studies have elucidated that miRNAs regulate various aspects of animal embryogenesis, with some miRNAs functioning in a tissue-specific manner.
MyomiRs are a muscle-enriched group of miRNAs, mainly composed of miR-1 and miR-133 families, including miR-1/miR-1-2/miR-206 and miR133a /miR-133b (Horak et al., 2016; Mok et al., 2017). Furthermore, miR-1 and miR-133 are potent repressors of non-muscle gene expression and cell fate during mouse and human embryonic stem cell differentiation (Ivey et al., 2008). In zebrafish, downregulation of miR-1 and miR-133 altered muscle gene expression and disrupted actin organization and sarcomere assembly during muscle differentiation (Mishima et al., 2009). During embryonic myogenesis, miR-1 and miR-133 actively shaped gene expression patterns. Among the set of myomiRs, miR-206 was detected in somites of chick and mouse embryos (Sweetman et al., 2006). Sweetman et al. (2008) demonstrated that the ectopic expression of MRFs in the developing chicken neural tube induced the expression of distinct myomiRs such as miR-1 and miR-206, whereas the lack of Myf-5 resulted in a loss of myomiR expression in developing somites. Their results indicated that myomiRs regulate myogenesis through MRFs. Additional gain- and loss-of-function experiments are needed to illustrate the role of myomiRs during myogenesis by affecting MRF expression. In Xenopus laevis, Vergara et al. examined the expression of miR-206 accompanying somitogenesis. Both knockdown and overexpression of miR-206 resulted in abnormal somite formation (Vergara et al., 2018). Conversely, miR-133 knockdown impaired myotome formation and growth, and the evolutionarily conserved miR-133 family mediated Gli3 silencing was critical for embryonic myogenesis (Mok et al., 2018). Other studies have specifically focused on the genetic analysis of myomiRs in a variety of model organisms, including flies, zebrafish, and mice (Sokol, 2012). MyomiRs are integrated into myogenic regulatory networks and, in turn, have widespread control of muscle gene expression.
In addition to myomiRs, several other miRNAs are involved in skeletal muscle embryonic development. For example, miR-196 reportedly acts upstream of Hoxb8 and Shh in vivo in the context of limb development, and primarily regulated the transcription of myogenesis (Hornstein et al., 2005). The zebrafish Myf5 locus has an intronic miRNA, termed miR-3906 or miR-In300, which was found to impair fast muscle differentiation by targeting Homer-1b or Dmrt2a, respectively, in zebrafish embryos (Lin et al., 2013). miR-203 was transiently upregulated in chicken embryos on days 10 to 16 (E10–E16)c and was sharply downregulated and not expressed after E16 in the chicken embryonic skeletal muscle. Histological profiles and weight variations of embryo skeletal muscle revealed that miR-203 expression correlates with muscle embryonic development (Luo et al., 2014). Collectively, these results demonstrated the expression and function of myomiRs in skeletal embryonic myogenesis.
Functional Analysis of miRNAs During Postnatal Muscle Development
In recent years, a fraction of miRNAs has been detected in the skeletal muscle. Herein, we systematically summarized the functions and regulatory mechanisms of miRNAs (Table 1) during postnatal skeletal muscle development.
Table 1
| miRNA | Functions | Mechanisms | Species | References |
|---|---|---|---|---|
| DmiR-1 | Required for the dramatic post-mitotic growth of larval muscle | Targets twist | Drosophila | Sokol and Ambros, 2005 |
| miR-1 | Promotes myoblast proliferation and differentiation | Targets HDAC4 | Mouse | Chen et al., 2006 |
| Maintains SCs quiescence and promotes self-renewal | Goat | Sui et al., 2020 | ||
| miR-181 | Required for skeletal myoblast terminal differentiation | Targets HoxA11 | Mouse | Naguibneva et al., 2006 |
| miR-214 | Modulation of Hedgehog (Hh) signaling in somite cells, enhance slow-muscle cell types | Targets suppressor of fused [su(fu)] | Zebrafish | Flynt et al., 2007 |
| Promotes myoblast differentiation | Targets Ezh2 | Mouse | Juan et al., 2009 | |
| miR-221/222 | Inhibits proliferation and differentiation | Targets p27 | Quail | Cardinali et al., 2009 |
| miR-208b/-499 | Activates slow and represses fast myofibers gene programs | Targets Sox6 | Mouse | van Rooij et al., 2009 |
| miR-27b | Promotes myoblast differentiation | Targets Pax3 | Mouse | Crist et al., 2009 |
| Promotes myoblast proliferation and differentiation | Goat | Ling et al., 2018 | ||
| Promotes myoblast differentiation | Inhibits MDFI expression | Porcine | Hou et al., 2018 | |
| miR-206 | Promotes myoblasts proliferation and differentiation | Targets Pax7 | Mouse | Chen et al., 2010 |
| miR-486 | Promotes myoblast differentiation | Targets Pax7 | Mouse | Dey et al., 2011 |
| miR-155 | Inhibits myoblast differentiation | Targets MEF2A | Mouse | Seok et al., 2011 |
| miR-125b | Inhibits myoblast differentiation | Targets IGF2 | Mouse | Ge et al., 2011 |
| miR-26a | Promotes myoblast differentiation | Targets Smad1 and Smad4 | Mouse | Dey et al., 2012 |
| miR-489 | Maintains SCs quiescence and regulates self-renewal | Post-transcriptionally suppresses the oncogene Dek | Mouse | Cheung et al., 2012 |
| miR-31 | Maintains SC quiescence | Sequesteres in mRNP granules together with Myf5 mRNAs. | Mouse | Crist et al., 2012 |
| miR-23a | Inhibits myogenic differentiation | Targets fast myosin heavy chain (Myh) genes, including Myh 1, 2 and 4 | Mouse | Cornu et al., 2012 |
| miR-128a | Negatively regulates myoblast proliferation and myotubes hypertrophy | Regulates IRS1/Akt insulin signaling | Mouse | Motohashi et al., 2013 |
| miR-675-3p/-5p | Promotes myoblast differentiation and regeneration | Targets Smad transcription factors | Mouse | Dey et al., 2014 |
| miR-146b | Promotes myogenic differentiation | Targets Smad4, Notch1, and Hmga2 | Mouse | Khanna et al., 2014 |
| miR-195/497 | Maintains SCs quiescence | Targets Ccnd1 and Ccnd2 | Mouse | Sato et al., 2014 |
| miR-186 | Inhibits myoblast differentiation | Targets myogenin | Mouse | Antoniou et al., 2014 |
| miR-30a | Promotes myogenesis by increasing apoptosis and altering somite morphology | Targets Six1 | Zebrafish | O'Brien et al., 2014 |
| miR-431 | Promotes differentiation and regeneration of old skeletal muscle | Targets Smad4 | Mouse and human | Lee et al., 2015 |
| miR-15b/miR-23b/miR-106b/miR-503 | Pitx2-miRNA pathway regulates myoblast proliferation | Targets CyclinD1 and CyclinD2 | Mouse | Lozano-Velasco et al., 2015 |
| miR-20a/20b | Promotes myoblast differentiation and represses myoblast proliferation | Targets E2F transcription factor 1 (E2F1) | Chicken | Luo et al., 2016 |
| miR-29a | Promotes SCs proliferation | Targets FGF2 | Mouse | Galimov et al., 2016 |
| miR-17-92 | Promotes myoblast proliferation but inhibits myotubes formation | Targets ENH1 | Mouse | Qiu et al., 2016 |
| miR-34c | Inhibits myoblast proliferation and promotes differentiation | A regulatory loop with Notch1 | Mouse | Hou et al., 2017 |
| miR-139 | Promotes SCs differentiation | Targets DHFR | Bovine | Zhou et al., 2018 |
| miR-708 | Activates SCs and regulates self-renewal | Antagonizes Tensin3 to inhibit FAK activation | Mouse | Baghdadi et al., 2018 |
| miR-487b-3p | Suppresses the proliferation and differentiation of myoblast | Targets IRS1 | Goat | Wang et al., 2018 |
| miR-17/19 | Promotes myoblast differentiation | miR-17 targets Ccnd2, Jak1 and Rhoc, miR-19 complement miR-17 | Mouse | Kong et al., 2019 |
| miR-208b | Promotes myoblast proliferation, inhibits differentiation | Targets the E-protein family member TCF12 | Mouse | Fu et al., 2020 |
| Stimulates fast-to-slow fiber conversion and oxidative metabolism programmers | Targets FNIP1 | |||
| miR-9-5p | Inhibits the proliferation and differentiation of SCs | Targets IGF2BP3 | Chicken | Yin et al., 2020 |
Functions and regulatory mechanisms of miRNAs in postnatal skeletal muscle development.
Several 100 miRNAs have been identified in plants, animals, and viruses by employing molecular cloning and bioinformatic approaches. In different tissues, miRNAs were found to downregulate gene expression by base-pairing with the 3′UTRs of target mRNAs; they also function this mechanism during myogenesis. For instance, miRNAs can influence proliferation via mRNAs coding regulators of the cell cycle. miR-27b is a functionally conserved miRNA that targets Pax3 to promote myoblast proliferation in mouse and goat (Crist et al., 2009; Ling et al., 2018). miR-195/497 is a positive regulator of SC quiescence by targeting Ccnd1 and Ccnd2 (Sato et al., 2014). The insulin-like growth factor (IGF) pathway, myocyte enhancer factor-2 (MEF2), and MRF factors play vital roles in myogenesis, miRNAs can regulate these pathways. For example, IGF-2, a critical regulator of skeletal myogenesis, is a direct and major target of miR-125b in both myocytes and regenerating muscles. miR-125b negatively modulated myoblast differentiation in vitro and muscle regeneration in vivo (Ge et al., 2011). MEF2A is a member of the MEF2 family of transcription factors, and miR-155 significantly suppressed the expression of MEF2A, repressing skeletal muscle differentiation (Seok et al., 2011). MRFs, including Myf5, MyoD, Myf6, and myogenin, regulate skeletal muscle differentiation, where myogenin plays a critical role in regulating the final stage of muscle differentiation. Antoniou et al. (2014) predicted that six miRNAs (miR-182, miR-186, miR-135, miR-491, miR-329, and miR-96) bind the myogenin 3′-UTR, but only miR-186 is a novel post-transcriptional regulator of myogenin during skeletal myogenesis. Recently, Fu et al. showed that miR-208b targeted the E-protein family member TCF12 to promote mouse myoblast proliferation and inhibit their differentiation. Meanwhile, miR-208b stimulated fast-to-slow fiber conversion and oxidative metabolism process by targeting FNIP1, thereby regulating postnatal muscle development (Fu et al., 2020). Several miRNAs are reportedly present in muscle cells and their modulating influence on myogenesis is likely to be overly complex. Some miRNAs target the same transcriptional networks in different species (Supplementary Table 1).
cicrRNA During Myogenesis
cicrRNA and Embryonic Myogenesis
With the advent of high-throughput sequencing and novel bioinformatic tools, thousands of circRNAs were discovered and their abundance and function were recorded (Salzman et al., 2012; Memczak et al., 2013). circRNAs are characterized by a covalently closed ring structure without 3′ and 5′ ends and are generated by precursor mRNA back-splicing of exons. Typically, the expression levels of circRNAs are low, often exhibiting cell- and tissue-specific patterns in eukaryotes (Li et al., 2018c). Increasing evidence has demonstrated that circRNAs participate in many steps of gene expression by acting as miRNA sponges, miRNA decoy, RNA-binding proteins (RBPs), as well as mediating RNA translation and protein interaction. Several studies have demonstrated that circRNAs possess coding capabilities (Panda et al., 2017). Owing to the non-linear conformation of circRNAs and lack of polyadenylated [poly (A)] tails, very few circRNAs can be identified by RNA-seq, but circRNAs are readily detectable in ribosomal RNA-depleted RNA-seq datasets (Greco et al., 2018). One microarray analysis found that 581 circRNAs were differentially regulated between C2C12 myoblasts and myotubes (Chen et al., 2018a). However, their roles remain to be explored. Notably, circRNAs may play a vital role in myogenesis. Fan et al. (2015) developed a single-cell universal poly(A)-independent RNA sequencing (SUPeR-seq) method to sequence both polyadenylated and non-polyadenylated RNAs from individual cells, discovering 2,891 circRNAs and 913 novel linear transcripts in mouse preimplantation embryos. This research is crucial to decipher functional regulators of circRNAs during early mammalian embryonic development. An increasing number of databases have suggested that skeletal muscle is one of the tissues enriched in circRNAs (Cheng et al., 2005; Li et al., 2017).
circSVIL, an exonic circular, was differentially expressed in chicken skeletal muscle at E11, E16, and post-hatching day 1 (P1) (Ouyang et al., 2018b). circSVIL functions as miR-203 sponges and upregulates levels of c-JUN and MEF2C, thereby promoting the proliferation and differentiation of myoblasts (Ouyang et al., 2018a). circFGFR2, generated by exon 3–6 of the FGFR2 gene, was differentially expressed during chicken embryo skeletal muscle development (Chen et al., 2018b). circFGFR2 directly targeted miR-133a-5p and miR-29b-1-5p and further eliminated the inhibitory effects of the two miRNAs on myoblast proliferation and differentiation (Chen et al., 2018b). The circRNA sequencing data of bovine skeletal muscle tissue demonstrated that circFUT10 was highly (but differentially) expressed in embryonic and adult skeletal muscle tissues. Reportedly, circFUT10 regulated myoblast differentiation and cell survival by directly binding to miR-133a and inhibiting miR-133a activity (Li et al., 2018b). circFUT10 may target myomiRs to regulate embryonic myogenesis. The expression level of circSNX29 was considerably higher in the bovine embryonic skeletal muscle than in adult skeletal muscle. circSNX29 directly interacted with miR-744 and efficiently reversed the suppression of Wnt5a and calcium/calmodulin–dependent protein kinase II delta (CaMKIIδ) (Peng et al., 2019). In bovine, enhancing circFUT10 or circSNX29 expression may emerge as a potential target in breeding strategies attempting to control muscle development. Overall, circRNAs play a role in regulating the myoblast cycle and development by acting as miRNA binding sites to facilitate the regulation of gene expression during myogenesis (Zhang et al., 2018a). In Duroc pigs, Hong et al. (2019) performed RNase R+RNA-seq in three distinct stages of embryonic skeletal muscle development (33, 65, and 90 days prenatal) to identify circRNAs and found that many circRNAs were specifically expressed at different embryonic stages. Collectively, these findings are helpful for further research on circRNAs in myogenesis.
circRNAs Regulating Postnatal Muscle Development
Here, we summarized the current research progress on the role of circRNAs in postnatal myogenesis (Table 2).
Table 2
| circRNA | Functions | Mechanisms | Species | References |
|---|---|---|---|---|
| circLMO7 | Inhibits myoblast differentiation and promotes myogenesis | miR-378a-3p sponge | Bovine | Wei et al., 2016 |
| circ-ZNF609 | Promotes myoblast proliferation | Protein encoding | Human | Legnini et al., 2017 |
| circRBFOX2 | Promotes myoblast proliferation | mir-206 sponge | Chicken | Ouyang et al., 2018b |
| circFGFR4 | Promotes myoblast differentiation and apoptosis | miR-107 sponge | Bovine | Li et al., 2018a |
| circ-Zfp609 | Inhibits myoblast differentiation | miR-194-5p sponge | Mouse | Wang et al., 2019b |
| circHIPK3 | Promotes myoblast proliferation and myogenesis | miR-30a-3p sponge | Chicken | Chen et al., 2019 |
| Promotes myoblast differentiation | miR-124 and miR-379 sopnge | Mouse | Yao et al., 2020 | |
| circ-FoxO3 | Inhibits myoblast differentiation | miR-138-5p sponge | Mouse | Li et al., 2019b |
| circTitin (circTTN) | Promotes proliferation and differentiation of bovine primary myoblast | miR-432 sponge | Bovine | Wang et al., 2019a |
| circTMTC1 | Inhibits chicken SMSC differentiation | miR-128-3p sponge | Chicken | Shen et al., 2019 |
| CDR1as (ciRS-7) | Promotes myogenic differentiation | miR-7 sponge | Goat | Li et al., 2019a |
| circHUWE1 | Facilitates myoblast proliferation, inhibits apoptosis and differentiation | miR-29b sponge | Bovine | Yue et al., 2020a |
| circSamd4 | Promotes myogenic differentiation | Associates with PUR proteins | Mouse | Pandey et al., 2020 |
| circINSR | Promotes proliferation and reduces apoptosis of bovine embryonic myoblast | miR-34a sponge | Bovine | Shen et al., 2020 |
Functions and regulatory mechanisms of circRNAs in skeletal muscle development.
Interestingly, almost all circRNAs can act as miRNA sponges to regulate the transcription and splicing of target genes. For example, circHIPK3 promoted the proliferation and differentiation of chicken myoblast cells by sponging miR-30a-3p binding to MEF2C (Chen et al., 2019). circHIPK3 can promote the differentiation of C2C12 myoblasts as a sponge of miR-124 and miR-379 (Yao et al., 2020). circINSR promoted proliferation and reduced apoptosis of bovine embryonic myoblasts by sponging miR-34a (Shen et al., 2020). Some circRNAs can be translated into proteins in the post-transcriptional regulation of muscle development. circ-ZNF609 specifically regulated mouse and human myoblast proliferation. circ-ZNF609 can be translated into a protein in a splicing-dependent and cap-independent manner when ectopically expressed (Legnini et al., 2017). circZfp609, the mouse homolog of circ-ZNF609, can sponge miR-194-5p to sequester its inhibition on BCLAF1 to repress myogenic differentiation (Wang et al., 2019b). Recently, researchers have shown that circSamd4, which is conserved between humans and mice, has a positive function in skeletal muscle differentiation by associating with PURA and PURB, two repressors of myogenesis that inhibit transcription of the myosin heavy chain (MHC) protein family (Pandey et al., 2020). This illustrated the protein interaction mechanism of circRNAs.
lncRNAs in Myogenesis
Role of lncRNAs in Regulating Embryonic Myogenesis
lncRNAs were originally considered as genomic transcription “noise” and account for a large proportion of total ncRNAs (Kapranov et al., 2007; Struhl, 2007). With weak or no protein-coding potential, lncRNAs are a class of RNA more than 200 nucleotides in length, possessing complex spatial structures and diverse functions (Derrien et al., 2012). Several lncRNAs are transcribed by RNA polymerase II (Pol II) from genomic loci with similar chromatin states to mRNAs; they are often 5′-capped, spliced, polyadenylated, with the absence of a translated open reading frame (ORF) (Quinn and Chang, 2016). lncRNAs are ubiquitous in organisms and are cell-type-specific, with poor evolutionary conservation among different species (Engreitz et al., 2016). Numerous studies have shown that lncRNAs are involved in the regulation of gene expression, epigenetics, cell differentiation, apoptosis, metabolism, signal transduction, and immune response (Mattick, 2005; Zhang et al., 2019). Interestingly, emerging studies have also demonstrated that some lncRNAs can encode micropeptides shorter than 100 amino acids to exert micropeptide-mediated functions (Anderson et al., 2015). Many computational pipelines developed from poly (A) RNA-seq in different cells can identify new lncRNAs, and several studies have shown that lncRNAs participate in embryo myogenesis.
H19 was one of the earliest known examples of imprinted lncRNAs that did not contain any conserved ORFs between mice and humans (Brannan et al., 1990). H19 is strongly repressed after birth in all mouse tissues, but it remains expressed in the skeletal muscle and heart in adults, suggesting an important function in these muscles (Poirier et al., 1991). Gabory and colleagues found that the H19 gene participates as a trans regulator in the fine-tuning of this imprinted gene network (IGN) in the mouse embryo (Gabory et al., 2009). This is the first in vivo evidence of a functional role for H19. Pauli et al. (2012) performed a time-series of RNA-seq experiments at eight stages during early zebrafish embryo development and observed that lncRNAs were particularly numerous during very early embryo development. In situ hybridization showed that lncRNAs are expressed in narrower time windows and are specifically enriched in early-stage embryos. Whole-mount in situ hybridization showed that lncIRS1 was expressed in the forming somites in the HH10 chick embryo, controlled IRS1 protein levels, and further activated the IGF-1 signaling pathway by functioning as ceRNA to sponge miR-15a, miR-15b-5p, and miR-15c-5p (Li et al., 2019c). Regarding lncRNAs in embryonic myogenesis, a review by Bouckenheimer et al. summarized their expression patterns and roles during early human embryo development and in pluripotent stem cells (PSCs). Importantly, abundant public mRNA sequencing (mRNA-seq) data have been used to illustrate the large number of lncRNAs expressed during embryo development (Bouckenheimer et al., 2016). These results support the notion that lncRNAs are part of dynamic changes in transcript expression occurring during mammalian early embryo development, including myogenesis. Sweta et al. suggested that lncRNAs are important for mesodermal specification and further differentiation, development, and functions of mesodermal derivatives, including lncRNA Evx1as, lncRNA HoxBlinc, and yylncT (Sweta et al., 2019). During embryonic development, the musculature of the adult body is derived from the mesoderm. Accordingly, these lncRNAs may function early myogenesis. However, insufficient evidence is available. Collectively, a better understanding of lncRNAs that can regulate the development of skeletal muscle will open potential avenues for their efficacious production, and enhance our knowledge regarding embryonic myogenesis development.
Functions and Mechanisms of lncRNAs in Postnatal Muscle Development
Numerous lncRNAs have been detected in skeletal muscle, but only a small fraction of lncRNAs have been characterized. Recent reports have indicated lncRNAs exert functional roles through multiple mechanisms, including transcription activation, molecular sponge activity, competitive binding, mRNA translation, and protein stability. Studies have shown that numerous lncRNAs interact with miRNAs to facilitate myogenesis. We displayed a known pattern of lncRNAs during skeletal muscle development (Figure 2; Supplementary Table 2).
Figure 2

lncRNA-miRNA-gene network regulates proliferation and differentiation of myoblast. lncRNAs are represented in red, miRNAs are represented in blue.
Notably, functions of lncRNAs are associated with their subcellular location and microenvironment (Chen, 2016). linc-YY1 activated gene expression in trans by interacting with YY1 and removing the YY1/PRC2 complex from target promoters such as Myh and Troponin, thus promoting muscle differentiation and regeneration (Zhou et al., 2015). SYISL interacted with Ezh2, the core component of PRC2, to regulate the expression of p21 and muscle-specific genes such as MyoG, MCK, and Myh4, leading to the promotion of myoblast proliferation and inhibition of myogenic differentiation (Jin et al., 2018). In the nucleus, lncRNAs can also bind to transcription factors or RBPs to influence transcription activation. For instance, lncRNA SRA promoted differentiation as a coregulator of MyoD, along with RNA helicase p68/p72 (Caretti et al., 2006; Hube et al., 2011). linc-RAM, which is induced by MyoD, interacts with MyoD, and supports the assembly of the MyoD-Baf60c-Brg complex to promote muscle growth and regeneration (Yu et al., 2017).
Most lncRNAs in the cytoplasm act as ceRNAs with miRNAs, such as lncMD1 (Cesana et al., 2011; Legnini et al., 2014), lnc-mg (Zhu et al., 2017; Du et al., 2019), and lnc-MAR1 (Zhang et al., 2018b). Recently, Li reported that 2310043L19Rik (lnc-231) inhibited differentiation and promoted proliferation of myoblasts as ceRNA to target miR-125a-5p, thereby inhibiting the function of E2F3 mRNA (Li et al., 2020b). Conversely, H19 can act as a molecular scaffold to recruit TDP43 to promoters of MyoD and activate transcription, thereby promoting porcine SC differentiation (Li et al., 2020a). Furthermore, some lncRNAs can give rise to functional micropeptides. A conserved lncRNA, LINC00961/5430416O09Rik, which is localized on the late endosome/lysosome and encodes a polypeptide of 90 amino acids termed small regulatory polypeptide of amino acid response (SPAR), interacted with lysosomal v-ATPase to negatively regulate mammalian target of rapamycin complex 1 (mTORC1) activation, as well as skeletal muscle regeneration (Matsumoto et al., 2017; Tajbakhsh, 2017). Myoregulin (MLN) and dwarf open reading frame (DWORF) are micropeptide-encoded tissue-specific putative lncRNAs, located at the sarcoplasmic reticulum membrane (Ivey et al.), and can directly bind SERCA; MLN inhibits SERCA activity and hinders the uptake of Ca2+ into the SR. However, DWORF increases SERCA activity by reducing exercise performance and Ca2+ uptake into the SR (Anderson et al., 2015; Nelson et al., 2016). As the sequence length of lncRNAs is larger than that of miRNAs and circRNAs, they function diverse mechanisms and play extensive roles in life processes.
Previous studies have focused on the function of ncRNAs in the nucleus and cytoplasm. Mitochondria are important organelles and the main energy metabolism sites in cells (Nunnari and Suomalainen, 2012). The roles of ncRNAs in mitochondria have become a new biology research topic (Bandiera et al., 2011). Barrey et al. for the first time demonstrated the presence of pre-miRNA and miRNA in the human mitochondria isolated from skeletal muscular cells (Barrey et al., 2011). The muscle-specific miR-1 is able to stimulate mitochondrial translation of multiple mtDNA-encoded transcripts, while repressing its nuclear DNA-encoded targets in the cytoplasm (Zhang et al., 2014). Some lncRNAs generated from the mammalian mitochondrial genome or located in mitochondria have been identified. Rackham et al. (2011) identified three lncRNAs generated from the mitochondrial genome named lncND5 RNA, lncND6 RNA and lncCytb RNA. Ro et al. reported that the mouse and human mitochondrial genomes encodes abundant small RNAs and named mitochondrial genome-encoded small RNAs (mitosRNAs), which may play an important regulatory role in the control of mitochondrial gene expression (Ro et al., 2013). The regulation mechanism and function of mitochondrial ncRNAs in myogenesis remain to be further explored.
As mentioned above, ncRNAs play an important role in regulating myogenesis during embryonic and adult stages. Crosstalk between miRNA-circRNA-lncRNA appears to be common in muscle development. lncRNAs can inhibit the function of miRNA through sequence-specific binding, whereas circRNAs can act as molecular sponges for miRNAs to regulate target mRNAs related to myogenesis. Further insights into postnatal skeletal muscle development will illustrate complex and dynamic regulatory networks.
ncRNAs in Muscle Disease
Skeletal muscle is a complex tissue in mammals, and skeletal muscle diseases are known to occur owing to physiological and pathological factors. Common skeletal muscle diseases include atrophy (Cohen et al., 2015), Duchenne muscular dystrophy (DMD) (Matsumura et al., 1994), and hypertrophy (Walters, 2017). Several reports have suggested that ncRNAs may play a functional role in muscle disease and could be potentially exploited as therapeutic tools. The impact of ncRNA dysregulation in muscle disease reported in recent years is depicted in Figure 3.
Figure 3

ncRNAs regulate muscle atrophy (A), hypertrophy (B), and dystrophy (C). lncRNAs are represented in red, miRNAs are represented in blue, circRNAs are represented in green. Myoblast, black nuclei; satlliate cells, blue nuclei.
An understanding of how ncRNAs regulate skeletal muscle functions and disease can provide novel therapeutic targets for the prevention and treatment of muscle pathologies in metabolic diseases. Two muscle-specific ubiquitin ligases, MAFbx/Atrogin-1 and muscle RING-finger 1 (MuRF1), are prominently induced during muscle atrophy and mediate atrophy-associated protein degradation (Sacheck et al., 2007). Blocking the expression of these two ubiquitin ligases affords protection against muscle atrophy. Wada and colleagues reported that miR-23a suppressed the translation of both MAFbx/Atrogin-1 and MuRF1 in a 3′-UTR-dependent manner. Ectopic expression of miR-23a was sufficient to protect the muscle from atrophy both in vitro and in vivo (Wada et al., 2011). Direct interactions were identified between miR-376c-3p and the 3′ UTR of Atrogin-1, leading to repression of Atrogin-1, and thereby induction of eIF3f protein levels in both human and mouse skeletal muscle cells (Shin et al., 2020). Reportedly, lncRNA Pvt1 is upregulated during muscle atrophy by blocking c-Myc phosphorylation and degradation. Functionally, Pvt1 affects mitochondrial respiration and morphology, thereby affecting muscle atrophy and myofiber size in vivo (Alessio et al., 2019). In addition to affecting myogenesis during embryonic and postnatal development, muscle disease is affected by miR-206. Loss of miR-206 accelerated and exacerbated the dystrophic phenotype in mdx mice by suppressing Pax7, Notch3, and Igfbp5 (Liu et al., 2012). In contrast, several lncRNAs are known to affect the pathological status of skeletal muscle dystrophy. lncRNA Atrolnc-1 was abundantly expressed in skeletal muscle and markedly increased in atrophying muscle. Atrolnc-1 strongly binds to ABIN-1, inhibits NF-κB signaling, and causes protein degradation in muscle cells (Sun et al., 2018). H19 can influence muscle hypertrophy by regulating the expression of Mstn and IGF2 (Martinet et al., 2016). Neppl and colleagues observed that lncRNA Chronos was expressed in muscles. Inhibition of Chronos induced myofiber hypertrophy both in vitro and in vivo through the epigenetic modulation of Bmp7 signaling (Neppl et al., 2017). Knockdown of lncRNA AK017368 promoted muscle hypertrophy in vivo. Notably, lncRNA AK017368 promoted proliferation and inhibited differentiation of myoblasts by competing with Tnrc6a for miR-30c (Liang et al., 2018).
Furthermore, circRNAs are associated with muscle disease. The dystrophy gene was among the first genes identified to generate circRNAs in skeletal muscle (Surono et al., 1999). Legnini et al. analyzed data from both normal and dystrophic human myoblasts and identified circ-QKI and circ-BNC2 upregulated during in vitro differentiation, and downregulated in the DMD conditions, which is consistent with the notion that dystrophic cells have altered progression into the differentiation process (Legnini et al., 2017). Song et al. identified 197 differentially expressed circRNAs between mdx mice and C57 mice by microarray analysis. A circRNA/miRNA interaction network was predicted by bioinformatic approaches (Song et al., 2020). These studies described the expression pattern of circRNAs and indicated that circRNAs may play pivotal roles in the pathophysiological mechanisms of DMD.
Conclusion and Future perspective
The discovery of ncRNAs has remarkably broadened our understanding of epigenetic regulation. Most researchers have used overexpression or inhibition of ncRNA function to explore their mechanisms during myogenesis; moreover, some ncRNAs have been well-investigated using in vivo mouse models. Several reports have revealed ncRNA functions in skeletal muscle development and disease and can be developed as novel biomarkers or targets for improving muscular abilities and therapeutic strategies.
Despite improvements in our knowledge regarding the role of ncRNAs in myogenesis, detailed identification and verification of ncRNAs still encounter several obstacles, including the following:
several techniques have been used to identify ncRNAs, including ncRNA microarray analysis and sequencing methods based on poly (A) sequencing, especially next-generation sequencing (NGS). The limitations of NGS on the identification of ncRNAs and its regulatory mechanisms need to be addressed as non-poly (A) forms of ncRNAs such as circRNAs are often ignored. Furthermore, there are a variety of ncRNA databases available, such as miRBase, TargetScan, ribosomal RNA-depleted RNA-seq datasets, lncRNA Database v2.0, and Linc2GO. We need to determine a systematic identification approach to combine ncRNA data generated from different methodologies.
Most known miRNAs and circRNAs demonstrate cytoplasmic localization, whereas lncRNAs are present in both the nucleoli and cytoplasm. Furthermore, nuclear miRNA-directed gene regulation constitutes a departure from the prevailing view of miRNA functions (Roberts, 2014), which requires different experimental schemes to identify functional ncRNAs. Fang et al. developed PIRCh-seq, a method that enables a comprehensive survey of chromatin-associated ncRNAs in a histone modification-specific manner (Fang et al., 2019). PIRCh-seq significantly reduces the influence of nascent transcripts and more precisely reveals relationships between chromatin and its associated ncRNAs than other sequencing methods. More recently, ribosome profiling, droplet digital PCR, and NanoString Technologies nCounter assays have uncovered the functions of ncRNAs (Chen, 2020).
Current experiments need to be based on the million-cell scale, and their accuracy does not support the single-cell level experiment. The current omics research field has been transformed from mixed sample research to single-cell level research. Single-cell sequencing technology has revealed the existence of cellular heterogeneity and related molecular mechanisms in detail. For some precious cell samples or embryonic samples, rigorous validation experiments are needed.
The mechanism of ncRNAs has been assessed via RIP, ChIRP, CHART, or GRID. One limitation of these probe approaches is that their efficacy is based on the size and location of ncRNAs. In recent years, many studies have reported that ncRNAs play biological functions through exosomes mediating intercellular communication (Romancino et al., 2013). Exosomes have been described as 40–100 nm vesicles that are secreted by a broad range of cell types and have been identified in diverse body fluids (Raposo and Stoorvogel, 2013). Exosomes have classically double membrane structure containing rich source of proteins, lipids, mRNAs and miRNA biological ingredients (Chevillet et al., 2014). The proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles showed that exosomes could regulate muscle development (Forterre et al., 2014b). Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation (Forterre et al., 2014a). Hudson et al. found that the expression of miR-23a in exosomes was altered, which weakened its inhibitory effect on target genes MuRf1 and atrogin-1, and leaded to muscle atrophy (Hudson et al., 2014). Mesenchymal-stem-cell-derived exosomes had low concentrations of muscle-repair-related cytokines and a number of repair-related miRNAs such as miR-494 to promote myogenesis and angiogenesis in vitro (Nakamura et al., 2015). There is growing evidence indicating active function of lncRNAs and circRNAs in exosomes (Yue et al., 2020b). Bioactive lncARSR (lncRNA Activated in RCC with Sunitinib Resistance) could be incorporated into exosomes and transmitted to sensitive cells, thus disseminating sunitinib resistance (Qu et al., 2016). H19 can be transferred from carcinoma-associated fibroblasts (CAFs) to colorectal cancer cells (CRCs) through exosomes, and acts as a competing endogenous RNA sponge for miR-141 in CRCs, promoting the stemness and chemoresistance of CRCs (Ren et al., 2018). However, the ncRNAs of exosomes related to myogenesis needs more in-depth analysis.
The functional interaction maps for a majority of characteristic ncRNAs with DNA or transcription factors, except for some well-studied cases, remain largely unknown. One crucial issue hindering the progression of this field is the limitations of RNA-DNA binding interaction technology and the lack of an ncRNAs-DNA-protein international database. Addressing these issues would significantly enhance our understanding of mechanisms that dictate ncRNAs association with myogenesis.
Furthermore, the identification of functional ncRNAs to improve muscle development remains a challenge that needs to be resolved. A major hindrance for most applications is the tissue delivery and distribution of ncRNAs for efficacy (Kaemmerer, 2018). For example, miRNAs function by integrating with complexes (RISC), which impedes their crossing of membranes; lncRNAs have low conservation between species, and their length and higher structure are complex. Currently, the most commonly used gene delivery methods for RNA-based therapeutics are recombinant viral systems such as adenovirus, lentivirus, and adeno-associated viruses (AAVs), which are employed either to inhibit or overexpress miRNAs, circRNAs, and lncRNAs (Sweta et al., 2019). Furthermore, the potential toxicity of the viral vectors should be determined to reduce negative impacts on the receptor. In addition to the delivery system for viral vectors, gene editing technology, antisense oligonucleotides (ASOs), and RNA interference (RNAi)-mediated approaches have also been reported. In recent years, the CRISPR/Cas9 system has been used as an efficient gene editing tool to investigate the function of ncRNAs. However, gene editing technology has presented off-target effects and ethical disputes. In contrast, the ASO technology has fewer off-target effects than the small RNA-mediated approach and the CRISPR/Cas9 system (Bennett and Swayze, 2010). To realize the full potential of ncRNAs as biomarkers or therapeutic targets against muscle, validation studies are warranted using both in vitro and in vivo systems to illustrate the integrated network of myogenesis.
Statements
Author contributions
HL and WL wrote the manuscript and selected the literature. BZ and ZX proposed the topic, wrote the manuscript, and corrected and gave suggestions to improve the manuscript. HL, WL, QT, JJ, ZX, and BZ reviewed the manuscript and prepared tables and figures. All authors read and approved the final manuscript.
Funding
This work was financially supported by the Key R&D projects of Hubei Province (2020BBB069), the National Key Project of Transgenic Research (Grant 2016ZX08006-002), the National Natural Science Foundation of China (Grant 31900448), the Agricultural Innovation Fund of Hubei Province (2016-620-000-001-043), the Fundamental Research Funds for the Central Universities (Program 2662018PY045), and the China Postdoctoral Science Foundation (Program 590319103).
Acknowledgments
We would like to thank Editage (www.editage.com) for English language editing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2021.628339/full#supplementary-material
References
1
AlessioE.BusonL.ChemelloF.PeggionC.GrespiF.MartiniP.et al. (2019). Single cell analysis reveals the involvement of the long non-coding RNA Pvt1 in the modulation of muscle atrophy and mitochondrial network. Nucleic Acids Res.47, 1653–1670. 10.1093/nar/gkz007
2
AndersonD. M.AndersonK. M.ChangC. L.MakarewichC. A.NelsonB. R.McAnallyJ. R.et al. (2015). A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell160, 595–606. 10.1016/j.cell.2015.01.009
3
AntoniouA.MastroyiannopoulosN. P.UneyJ. B.PhylactouL. A. (2014). miR-186 inhibits muscle cell differentiation through myogenin regulation. J. Biol. Chem.289, 3923–3935. 10.1074/jbc.M113.507343
4
BaghdadiM. B.FirminoJ.SoniK.EvanoB.Di GirolamoD.MourikisP.et al. (2018). Notch-induced miR-708 antagonizes satellite cell migration and maintains quiescence. Cell Stem Cell23, 859–868 e855. 10.1016/j.stem.2018.09.017
5
BandieraS.RubergS.GirardM.CagnardN.HaneinS.ChretienD.et al. (2011). Nuclear outsourcing of RNA interference components to human mitochondria. PLoS ONE6:e20746. 10.1371/journal.pone.0020746
6
BarreyE.Saint-AuretG.BonnamyB.DamasD.BoyerO.GidrolX. (2011). Pre-microRNA and mature microRNA in human mitochondria. PLoS ONE6:e20220. 10.1371/journal.pone.0020220
7
BartelD. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell136, 215–233. 10.1016/j.cell.2009.01.002
8
BennettC. F.SwayzeE. E. (2010). RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol.50, 259–293. 10.1146/annurev.pharmtox.010909.105654
9
BentzingerC. F.WangY. X.RudnickiM. A. (2012). Building muscle: molecular regulation of myogenesis. Cold Spring Harb. Perspect. Biol.4:a008342. 10.1101/cshperspect.a008342
10
BethuneJ.Artus-RevelC. G.FilipowiczW. (2012). Kinetic analysis reveals successive steps leading to miRNA-mediated silencing in mammalian cells. EMBO Rep.13, 716–723. 10.1038/embor.2012.82
11
BouckenheimerJ.AssouS.RiquierS.HouC.PhilippeN.SansacC.et al. (2016). Long non-coding RNAs in human early embryonic development and their potential in ART. Hum. Reprod. Update23, 19–40. 10.1093/humupd/dmw035
12
BrannanC. I.DeesE. C.IngramR. S.TilghmanS. M. (1990). The product of the H19 gene may function as an RNA. Mol. Cell. Biol.10, 28–36. 10.1128/MCB.10.1.28
13
BuckinghamM.RelaixF. (2007). The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu. Rev. Cell Dev. Biol.23, 645–673. 10.1146/annurev.cellbio.23.090506.123438
14
BushatiN.CohenS. M. (2007). microRNA functions. Annu. Rev. Cell Dev. Biol.23, 175–205. 10.1146/annurev.cellbio.23.090506.123406
15
CardinaliB.CastellaniL.FasanaroP.BassoA.AlemaS.MartelliF.et al. (2009). Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells. PLoS ONE4:e7607. 10.1371/journal.pone.0007607
16
CarettiG.SchiltzR. L.DilworthF. J.Di PadovaM.ZhaoP.OgryzkoV.et al. (2006). The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. Dev. Cell11, 547–560. 10.1016/j.devcel.2006.08.003
17
CesanaM.CacchiarelliD.LegniniI.SantiniT.SthandierO.ChinappiM.et al. (2011). A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell147, 358–369. 10.1016/j.cell.2011.09.028
18
ChenB.YuJ.GuoL.ByersM. S.WangZ.ChenX.et al. (2019). Circular RNA circHIPK3 promotes the proliferation and differentiation of chicken myoblast cells by sponging miR-30a-3p. Cells8:177. 10.3390/cells8020177
19
ChenJ. F.MandelE. M.ThomsonJ. M.WuQ.CallisT. E.HammondS. M.et al. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet.38, 228–233. 10.1038/ng1725
20
ChenJ. F.TaoY.LiJ.DengZ.YanZ.XiaoX.et al. (2010). microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J. Cell Biol.190, 867–879. 10.1083/jcb.200911036
21
ChenL. L. (2016). Linking long noncoding RNA localization and function. Trends Biochem. Sci.41, 761–772. 10.1016/j.tibs.2016.07.003
22
ChenL. L. (2020). The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat. Rev. Mol. Cell Biol.21, 475–490. 10.1038/s41580-020-0243-y
23
ChenR.JiangT.LeiS.SheY.ShiH.ZhouS.et al. (2018a). Expression of circular RNAs during C2C12 myoblast differentiation and prediction of coding potential based on the number of open reading frames and N6-methyladenosine motifs. Cell Cycle17, 1832–1845. 10.1080/15384101.2018.1502575
24
ChenX.OuyangH.WangZ.ChenB.NieQ. (2018b). A novel circular RNA generated by FGFR2 gene promotes myoblast proliferation and differentiation by sponging miR-133a-5p and miR-29b-1-5p. Cells7:199. 10.3390/cells7110199
25
ChengJ.KapranovP.DrenkowJ.DikeS.BrubakerS.PatelS.et al. (2005). Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science308, 1149–1154. 10.1126/science.1108625
26
CheungT. H.QuachN. L.CharvilleG. W.LiuL.ParkL.EdalatiA.et al. (2012). Maintenance of muscle stem-cell quiescence by microRNA-489. Nature482, 524–528. 10.1038/nature10834
27
CheungT. H.RandoT. A. (2013). Molecular regulation of stem cell quiescence. Nat. Rev. Mol. Cell Biol.14, 329–340. 10.1038/nrm3591
28
ChevilletJ. R.KangQ.RufI. K.BriggsH. A.VojtechL. N.HughesS. M.et al. (2014). Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc. Natl. Acad. Sci. U.S.A.111, 14888–14893. 10.1073/pnas.1408301111
29
ChoD. S.DolesJ. D. (2017). Single cell transcriptome analysis of muscle satellite cells reveals widespread transcriptional heterogeneity. Gene636, 54–63. 10.1016/j.gene.2017.09.014
30
CohenS.NathanJ. A.GoldbergA. L. (2015). Muscle wasting in disease: molecular mechanisms and promising therapies. Nat. Rev. Drug Discov.14, 58–74. 10.1038/nrd4467
31
ConsortiumE. P. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature489, 57–74. 10.1038/nature11247
32
CornuJ. N.TerrasaJ. B.CussenotO.HaabF.LukacsB. (2012). Evolution of the landscape of surgical management of prostate cancer in France: the case of radical prostatectomy. Eur. Urol.62, 735–736. 10.1016/j.eururo.2012.06.053
33
CristC. G.MontarrasD.BuckinghamM. (2012). Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules. Cell Stem Cell11, 118–126. 10.1016/j.stem.2012.03.011
34
CristC. G.MontarrasD.PallafacchinaG.RocancourtD.CumanoA.ConwayS. J.et al. (2009). Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc. Natl. Acad. Sci. U.S.A.106, 13383–13387. 10.1073/pnas.0900210106
35
de Gonzalo-CalvoD.ThumT. (2018). Circulating non-coding RNAs as biomarkers to predict and monitor the response to exercise: chances and hurdles. Eur. Heart J.39:3552. 10.1093/eurheartj/ehy457
36
DerrienT.JohnsonR.BussottiG.TanzerA.DjebaliS.TilgnerH.et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res.22, 1775–1789. 10.1101/gr.132159.111
37
DeyB. K.GaganJ.DuttaA. (2011). miR-206 and−486 induce myoblast differentiation by downregulating Pax7. Mol. Cell. Biol.31, 203–214. 10.1128/MCB.01009-10
38
DeyB. K.GaganJ.YanZ.DuttaA. (2012). miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev.26, 2180–2191. 10.1101/gad.198085.112
39
DeyB. K.PfeiferK.DuttaA. (2014). The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev.28, 491–501. 10.1101/gad.234419.113
40
DuJ.ZhangP.ZhaoX.HeJ.XuY.ZouQ.et al. (2019). MicroRNA-351-5p mediates skeletal myogenesis by directly targeting lactamase-beta and is regulated by lnc-mg. FASEB J.33, 1911–1926. 10.1096/fj.201701394RRR
41
EngreitzJ. M.HainesJ. E.PerezE. M.MunsonG.ChenJ.KaneM.et al. (2016). Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature539, 452–455. 10.1038/nature20149
42
FanX.ZhangX.WuX.GuoH.HuY.TangF.et al. (2015). Single-cell RNA-seq transcriptome analysis of linear and circular RNAs in mouse preimplantation embryos. Genome Biol.16:148. 10.1186/s13059-015-0706-1
43
FangJ.MaQ.ChuC.HuangB.LiL.CaiP.et al. (2019). PIRCh-seq: functional classification of non-coding RNAs associated with distinct histone modifications. Genome Biol.20:292. 10.1186/s13059-019-1880-3
44
FlyntA. S.LiN.ThatcherE. J.Solnica-KrezelL.PattonJ. G. (2007). Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat. Genet.39, 259–263. 10.1038/ng1953
45
ForterreA.JalabertA.BergerE.BaudetM.ChikhK.ErrazurizE.et al. (2014a). Proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles: a new paradigm for myoblast-myotube cross talk?PLoS ONE9:e84153. 10.1371/journal.pone.0084153
46
ForterreA.JalabertA.ChikhK.PesentiS.EuthineV.GranjonA.et al. (2014b). Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell Cycle13, 78–89. 10.4161/cc.26808
47
FuL.WangH.LiaoY.ZhouP.XuY.ZhaoY.et al. (2020). miR-208b modulating skeletal muscle development and energy homoeostasis through targeting distinct targets. RNA Biol.17, 743–754. 10.1080/15476286.2020.1728102
48
GaboryA.RipocheM. A.Le DigarcherA.WatrinF.ZiyyatA.ForneT.et al. (2009). H19 acts as a trans regulator of the imprinted gene network controlling growth in mice. Development136, 3413–3421. 10.1242/dev.036061
49
GalimovA.MerryT. L.LucaE.RushingE. J.MizbaniA.TurcekovaK.et al. (2016). MicroRNA-29a in adult muscle stem cells controls skeletal muscle regeneration during injury and exercise downstream of fibroblast growth factor-2. Stem Cells34, 768–780. 10.1002/stem.2281
50
GeY.SunY.ChenJ. (2011). IGF-II is regulated by microRNA-125b in skeletal myogenesis. J. Cell Biol.192, 69–81. 10.1083/jcb.201007165
51
GiraldezA. J.CinalliR. M.GlasnerM. E.EnrightA. J.ThomsonJ. M.BaskervilleS.et al. (2005). MicroRNAs regulate brain morphogenesis in zebrafish. Science308, 833–838. 10.1126/science.1109020
52
GrecoS.CardinaliB.FalconeG.MartelliF. (2018). Circular RNAs in muscle function and disease. Int. J. Mol. Sci.19:3454. 10.3390/ijms19113454
53
GrefteS.Kuijpers-JagtmanA. M.TorensmaR.Von den HoffJ. W. (2007). Skeletal muscle development and regeneration. Stem Cells Dev.16, 857–868. 10.1089/scd.2007.0058
54
GrosJ.ManceauM.ThomeV.MarcelleC. (2005). A common somitic origin for embryonic muscle progenitors and satellite cells. Nature435, 954–958. 10.1038/nature03572
55
GroundsM. D.Yablonka-ReuveniZ. (1993). Molecular and cell biology of skeletal muscle regeneration. Mol. Cell Biol. Hum. Dis. Ser.3, 210–256. 10.1007/978-94-011-1528-5_9
56
HongL.GuT.HeY.ZhouC.HuQ.WangX.et al. (2019). Genome-Wide Analysis Of Circular RNAs mediated ceRNA regulation in porcine embryonic muscle development. Front. Cell Dev. Biol.7:289. 10.3389/fcell.2019.00289
57
HorakM.NovakJ.Bienertova-VaskuJ. (2016). Muscle-specific microRNAs in skeletal muscle development. Dev. Biol.410, 1–13. 10.1016/j.ydbio.2015.12.013
58
HornsteinE.MansfieldJ. H.YektaS.HuJ. K.HarfeB. D.McManusM. T.et al. (2005). The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature438, 671–674. 10.1038/nature04138
59
HouL.XuJ.JiaoY.LiH.PanZ.DuanJ.et al. (2018). MiR-27b promotes muscle development by inhibiting MDFI expression. Cell. Physiol. Biochem.46, 2271–2283. 10.1159/000489595
60
HouL.XuJ.LiH.OuJ.JiaoY.HuC.et al. (2017). MiR-34c represses muscle development by forming a regulatory loop with Notch1. Sci. Rep.7:9346. 10.1038/s41598-017-09688-y
61
HubeF.VelascoG.RollinJ.FurlingD.FrancastelC. (2011). Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation. Nucleic Acids Res.39, 513–525. 10.1093/nar/gkq833
62
HudsonM. B.Woodworth-HobbsM. E.ZhengB.RahnertJ. A.BlountM. A.GoochJ. L.et al. (2014). miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export. Am. J. Physiol. Cell Physiol.306, C551–558. 10.1152/ajpcell.00266.2013
63
IveyK. N.MuthA.ArnoldJ.KingF. W.YehR. F.FishJ. E.et al. (2008). MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell2, 219–229. 10.1016/j.stem.2008.01.016
64
JinJ. J.LvW.XiaP.XuZ. Y.ZhengA. D.WangX. J.et al. (2018). Long noncoding RNA SYISL regulates myogenesis by interacting with polycomb repressive complex 2. Proc. Natl. Acad. Sci. U.S.A.115, E9802–E9811. 10.1073/pnas.1801471115
65
JinW.PengJ.JiangS. (2016). The epigenetic regulation of embryonic myogenesis and adult muscle regeneration by histone methylation modification. Biochem. Biophys. Rep.6, 209–219. 10.1016/j.bbrep.2016.04.009
66
JuanA. H.KumarR. M.MarxJ. G.YoungR. A.SartorelliV. (2009). Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol. Cell36, 61–74. 10.1016/j.molcel.2009.08.008
67
KaemmererW. F. (2018). How will the field of gene therapy survive its success?Bioeng. Transl. Med.3, 166–177. 10.1002/btm2.10090
68
KapranovP.ChengJ.DikeS.NixD. A.DuttaguptaR.WillinghamA. T.et al. (2007). RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science316, 1484–1488. 10.1126/science.1138341
69
KhannaN.GeY.ChenJ. (2014). MicroRNA-146b promotes myogenic differentiation and modulates multiple gene targets in muscle cells. PLoS ONE9:e100657. 10.1371/journal.pone.0100657
70
KongD.HeM.YangL.ZhouR.YanY. Q.LiangY.et al. (2019). MiR-17 and miR-19 cooperatively promote skeletal muscle cell differentiation. Cell. Mol. Life Sci.76, 5041–5054. 10.1007/s00018-019-03165-7
71
KuangS.KurodaK.Le GrandF.RudnickiM. A. (2007). Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell129, 999–1010. 10.1016/j.cell.2007.03.044
72
Le GrandF.RudnickiM. A. (2007). Skeletal muscle satellite cells and adult myogenesis. Curr. Opin. Cell Biol.19, 628–633. 10.1016/j.ceb.2007.09.012
73
LeeK. P.ShinY. J.PandaA. C.AbdelmohsenK.KimJ. Y.LeeS. M.et al. (2015). miR-431 promotes differentiation and regeneration of old skeletal muscle by targeting Smad4. Genes Dev.29, 1605–1617. 10.1101/gad.263574.115
74
LegniniI.Di TimoteoG.RossiF.MorlandoM.BrigantiF.SthandierO.et al. (2017). Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol. Cell66, 22–37 e29. 10.1016/j.molcel.2017.02.017
75
LegniniI.MorlandoM.MangiavacchiA.FaticaA.BozzoniI. (2014). A feedforward regulatory loop between HuR and the long noncoding RNA linc-MD1 controls early phases of myogenesis. Mol. Cell53, 506–514. 10.1016/j.molcel.2013.12.012
76
LiC.LiX.YaoY.MaQ.NiW.ZhangX.et al. (2017). Genome-wide analysis of circular RNAs in prenatal and postnatal muscle of sheep. Oncotarget8, 97165–97177. 10.18632/oncotarget.21835
77
LiH.WeiX.YangJ.DongD.HaoD.HuangY.et al. (2018a). circFGFR4 promotes differentiation of myoblasts via binding miR-107 to relieve its inhibition of Wnt3a. Mol. Ther. Nucleic Acids11, 272–283. 10.1016/j.omtn.2018.02.012
78
LiH.YangJ.WeiX.SongC.DongD.HuangY.et al. (2018b). CircFUT10 reduces proliferation and facilitates differentiation of myoblasts by sponging miR-133a. J. Cell. Physiol.233, 4643–4651. 10.1002/jcp.26230
79
LiJ.ZhaoW.LiQ.HuangZ.ShiG.LiC. (2020a). Long non-coding RNA H19 Promotes porcine satellite cell differentiation by interacting with TDP43. Genes11:259. 10.3390/genes11030259
80
LiL.ChenY.NieL.DingX.ZhangX.ZhaoW.et al. (2019a). MyoD-induced circular RNA CDR1as promotes myogenic differentiation of skeletal muscle satellite cells. Biochim. Biophys. Acta Gene Regul. Mech.1862, 807–821. 10.1016/j.bbagrm.2019.07.001
81
LiR.LiB.ShenM.CaoY.ZhangX.LiW.et al. (2020b). LncRNA 2310043L19Rik inhibits differentiation and promotes proliferation of myoblast by sponging miR-125a-5p. Aging12, 5625–5639. 10.18632/aging.102905
82
LiX.LiC.LiuZ.NiW.YaoR.XuY.et al. (2019b). Circular RNA circ-FoxO3 inhibits myoblast cells differentiation. Cells8:616. 10.3390/cells8060616
83
LiX.YangL.ChenL. L. (2018c). The biogenesis, functions, and challenges of circular RNAs. Mol. Cell71, 428–442. 10.1016/j.molcel.2018.06.034
84
LiZ.CaiB.AbdallaB. A.ZhuX.ZhengM.HanP.et al. (2019c). LncIRS1 controls muscle atrophy via sponging miR-15 family to activate IGF1-PI3K/AKT pathway. J. Cachexia Sarcopenia Muscle10, 391–410. 10.1002/jcsm.12374
85
LiangT.ZhouB.ShiL.WangH.ChuQ.XuF.et al. (2018). lncRNA AK017368 promotes proliferation and suppresses differentiation of myoblasts in skeletal muscle development by attenuating the function of miR-30c. FASEB J.32, 377–389. 10.1096/fj.201700560rr
86
LinC. Y.ChenJ. S.LooM. R.HsiaoC. C.ChangW. Y.TsaiH. J. (2013). MicroRNA-3906 regulates fast muscle differentiation through modulating the target gene homer-1b in zebrafish embryos. PLoS ONE8:e70187. 10.1371/journal.pone.0070187
87
LingY. H.SuiM. H.ZhengQ.WangK. Y.WuH.LiW. Y.et al. (2018). miR-27b regulates myogenic proliferation and differentiation by targeting Pax3 in goat. Sci. Rep.8:3909. 10.1038/s41598-018-22262-4
88
LiuN.WilliamsA. H.MaxeinerJ. M.BezprozvannayaS.SheltonJ. M.RichardsonJ. A.et al. (2012). microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest.122, 2054–2065. 10.1172/JCI62656
89
Lozano-VelascoE.VallejoD.EstebanF. J.DohertyC.Hernandez-TorresF.FrancoD.et al. (2015). A Pitx2-microRNA pathway modulates cell proliferation in myoblasts and skeletal-muscle satellite cells and promotes their commitment to a myogenic cell fate. Mol. Cell. Biol.35, 2892–2909. 10.1128/MCB.00536-15
90
LuoW.LiG.YiZ.NieQ.ZhangX. (2016). E2F1-miR-20a-5p/20b-5p auto-regulatory feedback loop involved in myoblast proliferation and differentiation. Sci. Rep.6:27904. 10.1038/srep27904
91
LuoW.WuH.YeY.LiZ.HaoS.KongL.et al. (2014). The transient expression of miR-203 and its inhibiting effects on skeletal muscle cell proliferation and differentiation. Cell Death Dis.5:e1347. 10.1038/cddis.2014.289
92
MartinetC.MonnierP.LouaultY.BenardM.GaboryA.DandoloL. (2016). H19 controls reactivation of the imprinted gene network during muscle regeneration. Development143, 962–971. 10.1242/dev.131771
93
MatsumotoA.PasutA.MatsumotoM.YamashitaR.FungJ.MonteleoneE.et al. (2017). mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature541, 228–232. 10.1038/nature21034
94
MatsumuraK.TomeF. M.CollinH.LeturcqF.JeanpierreM.KaplanJ. C.et al. (1994). Expression of dystrophin-associated proteins in dystrophin-positive muscle fibers (revertants) in Duchenne muscular dystrophy. Neuromuscul. Disord.4, 115–120. 10.1016/0960-8966(94)90002-7
95
MattickJ. S. (2005). The functional genomics of noncoding RNA. Science309, 1527–1528. 10.1126/science.1117806
96
MauroA. (1961). Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol.9, 493–495. 10.1083/jcb.9.2.493
97
MemczakS.JensM.ElefsiniotiA.TortiF.KruegerJ.RybakA.et al. (2013). Circular RNAs are a large class of animal RNAs with regulatory potency. Nature495, 333–338. 10.1038/nature11928
98
MishimaY.Abreu-GoodgerC.StatonA. A.StahlhutC.ShouC.ChengC.et al. (2009). Zebrafish miR-1 and miR-133 shape muscle gene expression and regulate sarcomeric actin organization. Genes Dev.23, 619–632. 10.1101/gad.1760209
99
MokG. F.Lozano-VelascoE.ManiouE.ViautC.MoxonS.WheelerG.et al. (2018). miR-133-mediated regulation of the Hedgehog pathway orchestrates embryo myogenesis. Development145:dev159657. 10.1242/dev.159657
100
MokG. F.Lozano-VelascoE.MunsterbergA. (2017). microRNAs in skeletal muscle development. Semin. Cell Dev. Biol.72, 67–76. 10.1016/j.semcdb.2017.10.032
101
MotohashiN.AlexanderM. S.Shimizu-MotohashiY.MyersJ. A.KawaharaG.KunkelL. M. (2013). Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis. J. Cell Sci.126(Pt 12), 2678–2691. 10.1242/jcs.119966
102
NaguibnevaI.Ameyar-ZazouaM.PolesskayaA.Ait-Si-AliS.GroismanR.SouidiM.et al. (2006). The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat. Cell Biol.8, 278–284. 10.1038/ncb1373
103
NakamuraY.MiyakiS.IshitobiH.MatsuyamaS.NakasaT.KameiN.et al. (2015). Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Lett.589, 1257–1265. 10.1016/j.febslet.2015.03.031
104
NelsonB. R.MakarewichC. A.AndersonD. M.WindersB. R.TroupesC. D.WuF.et al. (2016). A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science351, 271–275. 10.1126/science.aad4076
105
NepplR. L.WuC. L.WalshK. (2017). lncRNA Chronos is an aging-induced inhibitor of muscle hypertrophy. J. Cell Biol.216, 3497–3507. 10.1083/jcb.201612100
106
NunnariJ.SuomalainenA. (2012). Mitochondria: in sickness and in health. Cell148, 1145–1159. 10.1016/j.cell.2012.02.035
107
O'BrienJ. H.Hernandez-LagunasL.ArtingerK. B.FordH. L. (2014). MicroRNA-30a regulates zebrafish myogenesis through targeting the transcription factor Six1. J. Cell Sci.127(Pt 10), 2291–2301. 10.1242/jcs.143677
108
O'RourkeJ. R.GeorgesS. A.SeayH. R.TapscottS. J.McManusM. T.GoldhamerD. J.et al. (2007). Essential role for Dicer during skeletal muscle development. Dev. Biol.311, 359–368. 10.1016/j.ydbio.2007.08.032
109
OuyangH.ChenX.LiW.LiZ.NieQ.ZhangX. (2018a). Circular RNA circSVIL promotes myoblast proliferation and differentiation by sponging miR-203 in chicken. Front. Genet.9:172. 10.3389/fgene.2018.00172
110
OuyangH.ChenX.WangZ.YuJ.JiaX.LiZ.et al. (2018b). Circular RNAs are abundant and dynamically expressed during embryonic muscle development in chickens. DNA Res.25, 71–86. 10.1093/dnares/dsx039
111
PandaA. C.GrammatikakisI.MunkR.GorospeM.AbdelmohsenK. (2017). Emerging roles and context of circular RNAs. Wiley Interdiscip. Rev. RNA8:e1386. 10.1002/wrna.1386
112
PandeyP. R.YangJ. H.TsitsipatisD.PandaA. C.NohJ. H.KimK. M.et al. (2020). circSamd4 represses myogenic transcriptional activity of PUR proteins. Nucleic Acids Res.48, 3789–3805. 10.1093/nar/gkaa035
113
PauliA.RinnJ. L.SchierA. F. (2011). Non-coding RNAs as regulators of embryogenesis. Nat. Rev. Genet.12, 136–149. 10.1038/nrg2904
114
PauliA.ValenE.LinM. F.GarberM.VastenhouwN. L.LevinJ. Z.et al. (2012). Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res.22, 577–591. 10.1101/gr.133009.111
115
PengS.SongC.LiH.CaoX.MaY.WangX.et al. (2019). Circular RNA SNX29 sponges miR-744 to regulate proliferation and differentiation of myoblasts by activating the Wnt5a/Ca(2+) signaling pathway. Mol. Ther. Nucleic Acids16, 481–493. 10.1016/j.omtn.2019.03.009
116
PoirierF.ChanC. T.TimmonsP. M.RobertsonE. J.EvansM. J.RigbyP. W. (1991). The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development113, 1105–1114.
117
PorpigliaE.SamusikN.HoA. T. V.CosgroveB. D.MaiT.DavisK. L.et al. (2017). High-resolution myogenic lineage mapping by single-cell mass cytometry. Nat. Cell Biol.19, 558–567. 10.1038/ncb3507
118
QiuH.LiuN.LuoL.ZhongJ.TangZ.KangK.et al. (2016). MicroRNA-17-92 regulates myoblast proliferation and differentiation by targeting the ENH1/Id1 signaling axis. Cell Death Differ.23, 1658–1669. 10.1038/cdd.2016.56
119
QuL.DingJ.ChenC.WuZ. J.LiuB.GaoY.et al. (2016). Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell29, 653–668. 10.1016/j.ccell.2016.03.004
120
QuinnJ. J.ChangH. Y. (2016). Unique features of long non-coding RNA biogenesis and function. Nat. Rev. Genet.17, 47–62. 10.1038/nrg.2015.10
121
RackhamO.ShearwoodA. M.MercerT. R.DaviesS. M.MattickJ. S.FilipovskaA. (2011). Long noncoding RNAs are generated from the mitochondrial genome and regulated by nuclear-encoded proteins. RNA17, 2085–2093. 10.1261/rna.029405.111
122
RaposoG.StoorvogelW. (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol.200, 373–383. 10.1083/jcb.201211138
123
RelaixF.ZammitP. S. (2012). Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development139, 2845–2856. 10.1242/dev.069088
124
RenJ.DingL.ZhangD.ShiG.XuQ.ShenS.et al. (2018). Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics8, 3932–3948. 10.7150/thno.25541
125
RoS.MaH. Y.ParkC.OrtogeroN.SongR.HennigG. W.et al. (2013). The mitochondrial genome encodes abundant small noncoding RNAs. Cell Res.23, 759–774. 10.1038/cr.2013.37
126
RobertsT. C. (2014). The MicroRNA biology of the mammalian nucleus. Mol. Ther. Nucleic Acids3:e188. 10.1038/mtna.2014.40
127
RocheteauP.Gayraud-MorelB.Siegl-CachedenierI.BlascoM. A.TajbakhshS. (2012). A subpopulation of adult skeletal muscle stem cells retains all template DNA strands after cell division. Cell148, 112–125. 10.1016/j.cell.2011.11.049
128
RomancinoD. P.PaternitiG.CamposY.De LucaA.Di FeliceV.d'AzzoA.et al. (2013). Identification and characterization of the nano-sized vesicles released by muscle cells. FEBS Lett.587, 1379–1384. 10.1016/j.febslet.2013.03.012
129
SacheckJ. M.HyattJ. P.RaffaelloA.JagoeR. T.RoyR. R.EdgertonV. R.et al. (2007). Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J.21, 140–155. 10.1096/fj.06-6604com
130
SalzmanJ.GawadC.WangP. L.LacayoN.BrownP. O. (2012). Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE7:e30733. 10.1371/journal.pone.0030733
131
SambasivanR.TajbakhshS. (2007). Skeletal muscle stem cell birth and properties. Semin. Cell Dev. Biol.18, 870–882. 10.1016/j.semcdb.2007.09.013
132
SatoT.YamamotoT.Sehara-FujisawaA. (2014). miR-195/497 induce postnatal quiescence of skeletal muscle stem cells. Nat. Commun.5:4597. 10.1038/ncomms5597
133
SchraivogelD.MeisterG. (2014). Import routes and nuclear functions of Argonaute and other small RNA-silencing proteins. Trends Biochem. Sci.39, 420–431. 10.1016/j.tibs.2014.07.004
134
SeokH. Y.TatsuguchiM.CallisT. E.HeA.PuW. T.WangD. Z. (2011). miR-155 inhibits expression of the MEF2A protein to repress skeletal muscle differentiation. J. Biol. Chem.286, 35339–35346. 10.1074/jbc.M111.273276
135
ShenX.LiuZ.CaoX.HeH.HanS.ChenY.et al. (2019). Circular RNA profiling identified an abundant circular RNA circTMTC1 that inhibits chicken skeletal muscle satellite cell differentiation by sponging miR-128-3p. Int. J. Biol. Sci.15, 2265–2281. 10.7150/ijbs.36412
136
ShenX.ZhangX.RuW.HuangY.LanX.LeiC.et al. (2020). circINSR promotes proliferation and reduces apoptosis of embryonic myoblasts by sponging miR-34a. Mol. Ther. Nucleic Acids19, 986–999. 10.1016/j.omtn.2019.12.032
137
ShinY. J.KwonE. S.LeeS. M.KimS. K.MinK. W.LimJ. Y.et al. (2020). A subset of microRNAs in the Dlk1-Dio3 cluster regulates age-associated muscle atrophy by targeting Atrogin-1. J. Cachexia Sarcopenia Muscle11, 1336–1350. 10.1002/jcsm.12578
138
SokolN. S. (2012). The role of microRNAs in muscle development. Curr. Top. Dev. Biol.99, 59–78. 10.1016/B978-0-12-387038-4.00003-3
139
SokolN. S.AmbrosV. (2005). Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev.19, 2343–2354. 10.1101/gad.1356105
140
SongZ.LiuY.FangX.XieM.MaZ.ZhongZ.et al. (2020). Comprehensive analysis of the expression profile of circRNAs and their predicted protein-coding ability in the muscle of mdx mice. Funct. Integr. Genomics20, 397–407. 10.1007/s10142-019-00724-w
141
StruhlK. (2007). Transcriptional noise and the fidelity of initiation by RNA polymerase II. Nat. Struct. Mol. Biol.14, 103–105. 10.1038/nsmb0207-103
142
SuiM.ZhengQ.WuH.ZhuL.LingY.WangL.et al. (2020). The expression and regulation of miR-1 in goat skeletal muscle and satellite cell during muscle growth and development. Anim. Biotechnol.31, 455–462. 10.1080/10495398.2019.1622555
143
SunL.SiM.LiuX.ChoiJ. M.WangY.ThomasS. S.et al. (2018). Long-noncoding RNA Atrolnc-1 promotes muscle wasting in mice with chronic kidney disease. J. Cachexia Sarcopenia Muscle9, 962–974. 10.1002/jcsm.12321
144
SuronoA.TakeshimaY.WibawaT.IkezawaM.NonakaI.MatsuoM. (1999). Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing. Hum. Mol. Genet.8, 493–500. 10.1093/hmg/8.3.493
145
SweetmanD.GoljanekK.RathjenT.OustaninaS.BraunT.DalmayT.et al. (2008). Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133. Dev. Biol.321, 491–499. 10.1016/j.ydbio.2008.06.019
146
SweetmanD.RathjenT.JeffersonM.WheelerG.SmithT. G.WheelerG. N.et al. (2006). FGF-4 signaling is involved in mir-206 expression in developing somites of chicken embryos. Dev. Dyn.235, 2185–2191. 10.1002/dvdy.20881
147
SwetaS.DudnakovaT.SudheerS.BakerA. H.BhushanR. (2019). Importance of long non-coding RNAs in the development and disease of skeletal muscle and cardiovascular lineages. Front. Cell Dev. Biol.7:228. 10.3389/fcell.2019.00228
148
TajbakhshS. (2009). Skeletal muscle stem cells in developmental vs. regenerative myogenesis. J. Intern. Med266, 372–389. 10.1111/j.1365-2796.2009.02158.x
149
TajbakhshS. (2017). lncRNA-encoded polypeptide SPAR(s) with mTORC1 to regulate skeletal muscle regeneration. Cell Stem Cell20, 428–430. 10.1016/j.stem.2017.03.016
150
van RooijE.QuiatD.JohnsonB. A.SutherlandL. B.QiX.RichardsonJ. A.et al. (2009). A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell17, 662–673. 10.1016/j.devcel.2009.10.013
151
VergaraH. M.RamirezJ.RosingT.NaveC.BlandinoR.SawD.et al. (2018). miR-206 is required for changes in cell adhesion that drive muscle cell morphogenesis in Xenopus laevis. Dev. Biol.438, 94–110. 10.1016/j.ydbio.2018.03.021
152
WadaS.KatoY.OkutsuM.MiyakiS.SuzukiK.YanZ.et al. (2011). Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy. J. Biol. Chem.286, 38456–38465. 10.1074/jbc.M111.271270
153
WaltersJ. (2017). Muscle hypertrophy and pseudohypertrophy. Pract. Neurol.17, 369–379. 10.1136/practneurol-2017-001695
154
WangJ.TanJ.QiQ.YangL.WangY.ZhangC.et al. (2018). miR-487b-3p suppresses the proliferation and differentiation of myoblasts by targeting IRS1 in skeletal muscle myogenesis. Int. J. Biol. Sci.14, 760–774. 10.7150/ijbs.25052
155
WangX.CaoX.DongD.ShenX.ChengJ.JiangR.et al. (2019a). Circular RNA TTN acts as a miR-432 sponge to facilitate proliferation and differentiation of myoblasts via the IGF2/PI3K/AKT signaling pathway. Mol. Ther. Nucleic Acids18, 966–980. 10.1016/j.omtn.2019.10.019
156
WangY.LiM.WangY.LiuJ.ZhangM.FangX.et al. (2019b). A Zfp609 circular RNA regulates myoblast differentiation by sponging miR-194-5p. Int. J. Biol. Macromol.121, 1308–1313. 10.1016/j.ijbiomac.2018.09.039
157
WeiX.LiH.ZhangB.LiC.DongD.LanX.et al. (2016). miR-378a-3p promotes differentiation and inhibits proliferation of myoblasts by targeting HDAC4 in skeletal muscle development. RNA Biol.13, 1300–1309. 10.1080/15476286.2016.1239008
158
YaoR.YaoY.LiC.LiX.NiW.QuanR.et al. (2020). Circ-HIPK3 plays an active role in regulating myoblast differentiation. Int. J. Biol. Macromol.155, 1432–1439. 10.1016/j.ijbiomac.2019.11.119
159
YinH.HeH.ShenX.ZhaoJ.CaoX.HanS.et al. (2020). miR-9-5p inhibits skeletal muscle satellite cell proliferation and differentiation by targeting IGF2BP3 through the IGF2-PI3K/Akt signaling pathway. Int. J. Mol. Sci.21:1655. 10.3390/ijms21051655
160
YuX.ZhangY.LiT.MaZ.JiaH.ChenQ.et al. (2017). Long non-coding RNA Linc-RAM enhances myogenic differentiation by interacting with MyoD. Nat. Commun.8:14016. 10.1038/ncomms14016
161
YueB.WangJ.RuW.WuJ.CaoX.YangH.et al. (2020a). The circular RNA circHUWE1 sponges the miR-29b-AKT3 axis to regulate myoblast development. Mol. Ther. Nucleic Acids19, 1086–1097. 10.1016/j.omtn.2019.12.039
162
YueB.YangH.WangJ.RuW.WuJ.HuangY.et al. (2020b). Exosome biogenesis, secretion and function of exosomal miRNAs in skeletal muscle myogenesis. Cell Prolif.53:e12857. 10.1111/cpr.12857
163
ZammitP. S. (2017). Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis. Semin. Cell Dev. Biol.72, 19–32. 10.1016/j.semcdb.2017.11.011
164
ZammitP. S.PartridgeT. A.Yablonka-ReuveniZ. (2006). The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem.54, 1177–1191. 10.1369/jhc.6R6995.2006
165
ZhangP.XuH.LiR.WuW.ChaoZ.LiC.et al. (2018a). Assessment of myoblast circular RNA dynamics and its correlation with miRNA during myogenic differentiation. Int. J. Biochem. Cell Biol.99, 211–218. 10.1016/j.biocel.2018.04.016
166
ZhangX.WangW.ZhuW.DongJ.ChengY.YinZ.et al. (2019). Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int. J. Mol. Sci.20:5573. 10.3390/ijms20225573
167
ZhangX.ZuoX.YangB.LiZ.XueY.ZhouY.et al. (2014). MicroRNA directly enhances mitochondrial translation during muscle differentiation. Cell158, 607–619. 10.1016/j.cell.2014.05.047
168
ZhangZ. K.LiJ.GuanD.LiangC.ZhuoZ.LiuJ.et al. (2018b). A newly identified lncRNA MAR1 acts as a miR-487b sponge to promote skeletal muscle differentiation and regeneration. J. Cachexia Sarcopenia Muscle9, 613–626. 10.1002/jcsm.12281
169
ZhouL.SunK.ZhaoY.ZhangS.WangX.LiY.et al. (2015). Linc-YY1 promotes myogenic differentiation and muscle regeneration through an interaction with the transcription factor YY1. Nat. Commun.6:10026. 10.1038/ncomms10026
170
ZhouS.LiS.ZhangW.TongH.LiS.YanY. (2018). MiR-139 promotes differentiation of bovine skeletal muscle-derived satellite cells by regulating DHFR gene expression. J. Cell. Physiol.234, 632–641. 10.1002/jcp.26817
171
ZhuM.LiuJ.XiaoJ.YangL.CaiM.ShenH.et al. (2017). Lnc-mg is a long non-coding RNA that promotes myogenesis. Nat. Commun.8:14718. 10.1038/ncomms14718
172
ZierathJ. R.HawleyJ. A. (2004). Skeletal muscle fiber type: influence on contractile and metabolic properties. PLoS Biol.2:e348. 10.1371/journal.pbio.0020348
Summary
Keywords
myogenesis, muscle disease, miRNAs, lncRNAs, circRNAs
Citation
Luo H, Lv W, Tong Q, Jin J, Xu Z and Zuo B (2021) Functional Non-coding RNA During Embryonic Myogenesis and Postnatal Muscle Development and Disease. Front. Cell Dev. Biol. 9:628339. doi: 10.3389/fcell.2021.628339
Received
11 November 2020
Accepted
06 January 2021
Published
28 January 2021
Volume
9 - 2021
Edited by
Tomokazu Tomo Fukuda, Iwate University, Japan
Reviewed by
XiuKai Cao, Yangzhou University, China; Constantinos Demonacos, The University of Manchester, United Kingdom
Updates
Copyright
© 2021 Luo, Lv, Tong, Jin, Xu and Zuo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zaiyan Xu xuzaiyan@mail.hzau.edu.cnBo Zuo zuobo@mail.hzau.edu.cn
This article was submitted to Cell Growth and Division, a section of the journal Frontiers in Cell and Developmental Biology
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.